Related Experiment Video
Updated: Mar 20, 2026
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
Evasion of cell senescence in SHH medulloblastoma
Lukas Tamayo-Orrego1,2, Shannon M Swikert1,2, Frédéric Charron1,2,3,4
1a Molecular Biology of Neural Development , Institut de Recherches Cliniques de Montréal (IRCM) , Montreal , Quebec , Canada.
Abstract:
The mechanisms leading to brain tumor formation are poorly understood. Using Ptch1+/- mice as a medulloblastoma model, sequential mutations were found to shape tumor evolution. Initially, medulloblastoma preneoplastic lesions display loss of heterozygosity of the Ptch1 wild-type allele, an event associated with cell senescence in preneoplasia. Subsequently, p53 mutations lead to senescence evasion and progression from preneoplasia to medulloblastoma. These findings are consistent with a model where high levels of Hedgehog signaling caused by the loss of the tumor suppressor Ptch1 lead to oncogene-induced senescence and drive p53 mutations. Thus, cell senescence is an important characteristic of a subset of SHH medulloblastoma and might explain the acquisition of somatic TP53 mutations in human medulloblastoma. This mode of medulloblastoma formation contrasts with the one characterizing Li-Fraumeni patients with medulloblastoma, where TP53 germ-line mutations cause chromothriptic genomic instability and lead to mutations in Hedgehog signaling genes, which drive medulloblastoma growth. Here we discuss in detail these 2 alternative mechanisms leading to medulloblastoma tumorigenesis.
Insights
Brain tumor formation involves sequential mutations. Loss of Ptch1 leads to senescence, evasion of which drives medulloblastoma, contrasting with Li-Fraumeni cases where TP53 mutations initiate tumor development.
Area of Science:
- Oncology
- Genetics
- Developmental Biology
Background:
- Brain tumor formation mechanisms, particularly medulloblastoma, remain incompletely understood.
- The role of specific genetic mutations and cellular processes like senescence in tumor evolution requires further elucidation.
Purpose of the Study:
- To investigate the sequential genetic events and cellular mechanisms driving medulloblastoma formation.
- To compare two distinct pathways of medulloblastoma tumorigenesis: one involving Ptch1 loss and senescence, and another related to Li-Fraumeni syndrome.
Main Methods:
- Utilized Ptch1+/- mice as a model system for studying medulloblastoma.
- Analyzed sequential mutations, loss of heterozygosity, and cellular senescence in preneoplastic lesions and tumors.
Main Results:
- Medulloblastoma preneoplastic lesions showed loss of the Ptch1 wild-type allele, linked to cell senescence.
- p53 mutations enabled senescence evasion, facilitating progression from preneoplasia to medulloblastoma.
- High Hedgehog signaling due to Ptch1 loss induced senescence and promoted p53 mutations.
Conclusions:
- Cell senescence is a key feature in a subset of SHH medulloblastoma, potentially explaining somatic TP53 mutations in human cases.
- Two alternative medulloblastoma formation mechanisms exist: one driven by senescence evasion and another by germline TP53 mutations causing genomic instability.
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:15Replicative Cell Senescence
02:15Replicative Cell Senescence
02:33Hedgehog Signaling Pathway
02:23Abnormal Proliferation
01:23Negative Regulator Molecules